Dr. Agarwal's Health Care Statistics
Total Valuation
NSE:AGARWALEYE has a market cap or net worth of INR 130.33 billion. The enterprise value is 136.30 billion.
Market Cap | 130.33B |
Enterprise Value | 136.30B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NSE:AGARWALEYE has 315.88 million shares outstanding. The number of shares has increased by 4.04% in one year.
Current Share Class | n/a |
Shares Outstanding | 315.88M |
Shares Change (YoY) | +4.04% |
Shares Change (QoQ) | +8.43% |
Owned by Insiders (%) | 30.64% |
Owned by Institutions (%) | 0.16% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 133.72.
PE Ratio | 133.72 |
Forward PE | n/a |
PS Ratio | 7.47 |
PB Ratio | 8.44 |
P/TBV Ratio | 42.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 152.06 |
EV / Sales | 8.52 |
EV / EBITDA | 32.38 |
EV / EBIT | 63.14 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.66 |
Debt / EBITDA | 2.46 |
Debt / FCF | n/a |
Interest Coverage | 1.94 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 3.29M |
Profits Per Employee | 184,522 |
Employee Count | 4,214 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 3,255,715 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AGARWALEYE had revenue of INR 16.00 billion and earned 896.41 million in profits. Earnings per share was 3.09.
Revenue | 16.00B |
Gross Profit | 6.81B |
Operating Income | 2.16B |
Pretax Income | 1.55B |
Net Income | 896.41M |
EBITDA | 3.56B |
EBIT | 2.16B |
Earnings Per Share (EPS) | 3.09 |
Balance Sheet
The company has 4.91 billion in cash and 10.34 billion in debt, giving a net cash position of -5.44 billion or -17.21 per share.
Cash & Cash Equivalents | 4.91B |
Total Debt | 10.34B |
Net Cash | -5.44B |
Net Cash Per Share | -17.21 |
Equity (Book Value) | 15.58B |
Book Value Per Share | 48.91 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 42.57%, with operating and profit margins of 13.50% and 5.60%.
Gross Margin | 42.57% |
Operating Margin | 13.50% |
Pretax Margin | 9.72% |
Profit Margin | 5.60% |
EBITDA Margin | 22.28% |
EBIT Margin | 13.50% |
FCF Margin | n/a |
Dividends & Yields
NSE:AGARWALEYE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.04% |
Shareholder Yield | -4.04% |
Earnings Yield | 0.69% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |